Evidence map›Paper›PMID 32711928›Full record

ArticleAnais brasileiros de dermatologia

Evaluation of monocyte to HDL cholesterol ratio and other inflammatory markers in patients with psoriasis.

Mumtaz Cem Sirin, Selma Korkmaz, Ijlal Erturan, Basak Filiz, Buket Cicioglu Aridogan, Emel Sesli Cetin, Mehmet Yildirim

Abstract read
In one paragraph

Article in Anais brasileiros de dermatologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Investigation of Peripheral Inflammatory Biomarkers in Trichotillomania.Turk psikiyatri dergisi = Turkish journal of psychiatry · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Psoriasis: What Is New in Markers of Disease Severity?Medicina (Kaunas, Lithuania) · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mumtaz Cem SirinDepartment of Medical Microbiology, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey. Electronic address: drmcemsirin@yahoo.com.
Selma KorkmazDepartment of Dermatology, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey.
Ijlal ErturanDepartment of Dermatology, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey.
Basak FilizDepartment of Dermatology, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey.
Buket Cicioglu AridoganDepartment of Medical Microbiology, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey.
Emel Sesli CetinDepartment of Medical Microbiology, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey.
Mehmet YildirimDepartment of Dermatology, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPsoriasis is a chronic systemic inflammatory disease frequently associated with serious comorbidities.

objectivesTo investigate the systemic inflammatory burden in psoriasis and to assess the correlation between traditional and novel inflammatory markers and the severity of the disease.

methodsThis cross-sectional study was conducted on 60 patients with psoriasis vulgaris and 50 healthy volunteers. Data including demographics, Psoriasis Area and Severity Index scores, and laboratory results were analyzed and compared.

resultsCompared with the control group, the psoriatic patients had significantly higher high sensitive C-reactive protein, serum amyloid A, erythrocyte sedimentation rate, leukocyte, neutrophil, neutrophil-to-lymphocyte ratio, monocyte to high density lipoprotein (HDL) cholesterol ratio, and aspartate aminotransferase levels, and significantly lower HDL cholesterol levels (p < 0.05). No significant difference was found in procalcitonin, lymphocyte, monocyte, hemoglobin, red blood cell distribution width, platelet, mean platelet volume, platelet distribution width, lymphocyte-to-monocyte ratio, anti-cyclic citrullinated peptide, glucose, alanine aminotransaminase, blood urea nitrogen, creatinine, triglyceride, total cholesterol, and LDL cholesterol levels between the two groups (p > 0.05). The Psoriasis Area and Severity Index score was positively correlated with high-sensitivity C-reactive protein, serum amyloid A, and monocyte to HDL cholesterol ratio, and negatively correlated with lymphocyte-to-monocyte ratio (p < 0.05). STUDY LIMITATIONS: This was a single-center study with relatively limited numbers of patients and controls.

conclusionsThe data show that high sensitivity C-reactive protein, serum amyloid A, erythrocyte sedimentation rate, neutrophil-to-lymphocyte ratio, and monocyte to HDL cholesterol ratio can be used as markers of systemic inflammation in patients with psoriasis. Moreover, high sensitivity C-reactive protein, serum amyloid A, monocyte to HDL cholesterol ratio and lymphocyte-to-monocyte ratio are closely related to the Psoriasis Area and Severity Index score, and they may be regarded as objective indicators in determining the disease severity.

Indexed as

MonocytesPsoriasisBiomarkersCholesterol, HDLCross-Sectional StudiesHumansBiomarkersCholesterol, HDLBiological markersCholesterol, HDLC-Reactive proteinInflammationMonocytesPsoriasisSerum amyloid A protein

Identifiers

PMID32711928
PMCPMC7562997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.